Due to the decreased excretion in CKD, serum phosphate is elevated, and vitamin D insufficiently activated with a consequent parathyroid hormone hypersecretion (secondary hyperparathyroidism) that in turn leads to an increased calcium–phosphate product and vascular calcification development. The gene discussed is PTH; the disease is chronic kidney disease.